Head-to-head · Cost-Efficiency Index
YOURx Health vs SexyMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
YOURx Health
Cost-first shoppers who want comparing real per-product flat pricing without needing a published state list up front.
Visit YOURx HealthSexyMD
Readers willing to commit 48 weeks up front, where the advertised figure is the one actually charged.
Visit SexyMDThe verdict
YOURx Health and SexyMD tie on the Cost-Efficiency Index at 68/100, so neither wins outright on the numbers. For most shoppers we'd start with YOURx Health (ranked #115, a hair above #119) — Cost-first shoppers who want comparing real per-product flat pricing without needing a published state list up front. But SexyMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs YOURx Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | YOURx Health | SexyMD |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 68/100 |
| Semaglutide / mo | $169/mo (all doses, promotional rate, bundle, compounded) | $269/mo on the four-week plan (the site's "from $199" is the 48-week commitment rate) |
| Tirzepatide / mo | $189/mo (all doses, promotional rate, compounded) | $369/mo on the four-week plan (the site's "from $299" is the 48-week commitment rate) |
| Semaglutide / yr (modeled) | $2,028 | $3,228 |
| Tirzepatide / yr (modeled) | $2,268 | $4,428 |
| Coverage | Coverage not published | 47 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #115 | #119 |
YOURx Health
68/100Where the value is
- Real per-product pricing published on individual treatment pages, not just a vague 'starting at' banner: $169/mo semaglutide injection, $189/mo tirzepatide injection, $159/mo and $179/mo oral-tablet equivalents
- Listed price is genuinely all-in — physician consultation, supplies, and shipping are bundled with no separate visit or shipping fee shown
- Both injectable and oral (RDT tablet) formulations offered for each drug, a needle-free option many peer sites lack
The tradeoffs
- Every price is explicitly labeled 'New Patient' with no disclosure of what it becomes afterward — the true ongoing cost is unknown
- The homepage's state-coverage counter literally reads 'Coverage 0 States,' a broken/placeholder metric that leaves real coverage unverifiable from the site itself
SexyMD
68/100Where the value is
- Publishes a full four-rung price table for each molecule on its product pages, before any intake
- States both pharmacy classes it uses and discloses that a prescription may be routed to, and transferred between, any pharmacy in that network
- Names the professional entities its prescribers work through, rather than referring only to licensed providers
The tradeoffs
- Every headline on the site quotes the 48-week rate: "from $199 per month" against a four-week price of $269, and "from $299" against $369, with an asterisk that resolves to no footnote
- The same footer block says both "available in all 50 states" and "available in all states except Arkansas, Mississippi, and New Jersey", on all eleven pages
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.